A dose-finding study of duloxetine based on serotonin transporter occupancy
- 28 February 2006
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 185 (3), 395-399
- https://doi.org/10.1007/s00213-005-0304-0
Abstract
Positron emission tomography (PET) has been utilized for determining the dosage of antipsychotic drugs. To evaluate the dosage of antidepressants such as selective serotonin reuptake inhibitors, serotonin transporter occupancy (5-HTT) is also a useful index. We investigated the degree of 5-HTT occupancy with different doses of the antidepressant duloxetine and the time-course of 5-HTT occupancy using PET. PET scans with [11C]DASB were performed before and after a single administration of duloxetine (5–60 mg), and three consecutive scans were performed after a single dose or repeated doses of 60 mg of duloxetine. 5-HTT occupancies by duloxetine were increased by 35.3 to 86.5% with dose and plasma concentration increments. The ED50 value of 5-HTT occupancy was 7.9 mg for dose and 3.7 ng/ml for plasma concentration. In the time-course of 5-HTT occupancy, mean occupancies were 81.8% at 6 h, 71.9% at 25 h, and 44.9% at 53 h after a single administration, and 84.3% at 6 h, 71.9% at 49 h, and 47.1% at 78 h after repeated administrations. Based on 5-HTT occupancy, 40 mg and more of duloxetine was needed to attain 80% occupancy, and 60 mg of duloxetine could maintain a high level of 5-HTT occupancy with a once-a-day administration schedule.Keywords
This publication has 28 references indexed in Scilit:
- Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studiesJournal of Psychiatric Research, 2005
- Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography StudyAmerican Journal of Psychiatry, 2004
- Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trialEuropean Neuropsychopharmacology, 2004
- Linearized Reference Tissue Parametric Imaging Methods: Application to [11C]DASB Positron Emission Tomography Studies of the Serotonin Transporter in Human BrainJournal of Cerebral Blood Flow & Metabolism, 2003
- Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depressionJournal of Psychiatric Research, 2002
- Comparative Affinity of Duloxetine and Venlafaxine for Serotonin and Norepinephrine Transporters in vitro and in vivo, Human Serotonin Receptor Subtypes, and Other Neuronal ReceptorsNeuropsychopharmacology, 2001
- Occupancy of Serotonin Transporters by Paroxetine and Citalopram During Treatment of Depression: A [11C]DASB PET Imaging StudyAmerican Journal of Psychiatry, 2001
- Assessment of the Serotonin and Norepinephrine Reuptake Blocking Properties of Duloxetine in Healthy SubjectsNeuropsychopharmacology, 2001
- Novel Radiotracers for Imaging the Serotonin Transporter by Positron Emission Tomography: Synthesis, Radiosynthesis, and in Vitro and ex Vivo Evaluation of 11C-Labeled 2-(Phenylthio)araalkylaminesJournal of Medicinal Chemistry, 2000
- Duloxetine (LY 248686): an inhibitor of serotonin and noradrenaline uptake and an antidepressant drug candidateExpert Opinion on Investigational Drugs, 1998